scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1020453966 |
P356 | DOI | 10.1038/MODPATHOL.2015.5 |
P698 | PubMed publication ID | 25676557 |
P2093 | author name string | Albert Su | |
Rajan P Kulkarni | |||
Xinmin Li | |||
Alistair J Cochran | |||
Scott W Binder | |||
Seong H Ra | |||
Jaime Zhou | |||
P2860 | cites work | Perforin activates clathrin- and dynamin-dependent endocytosis, which is required for plasma membrane repair and delivery of granzyme B for granzyme-mediated apoptosis | Q28574249 |
Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. | Q33201339 | ||
Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion | Q34102814 | ||
Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization | Q36711040 | ||
Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? | Q37665443 | ||
Keratoacanthoma clinical behavior: a systematic review | Q38173658 | ||
The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth | Q39442136 | ||
Molecularly enriched pathways and differentially expressed genes distinguishing cutaneous squamous cell carcinoma from pseudoepitheliomatous hyperplasia | Q39474695 | ||
MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis | Q39556569 | ||
Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines | Q39558994 | ||
Molecular discrimination of cutaneous squamous cell carcinoma from actinic keratosis and normal skin | Q39730392 | ||
S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells | Q39767672 | ||
Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma | Q39991093 | ||
Profile of Ets gene expression in human breast carcinoma | Q40195338 | ||
Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases | Q40768677 | ||
Keratoacanthoma: a deficient squamous cell carcinoma? Study of bcl-2 expression. | Q42484208 | ||
Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. | Q42496571 | ||
The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus | Q42709296 | ||
Genetic profiling of BRAF inhibitor-induced keratoacanthomas reveals no induction of MAP kinase pathway expression | Q43485598 | ||
EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study | Q43523031 | ||
Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival | Q44426138 | ||
Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers | Q46620151 | ||
Induction of apoptotic cell death in mouse lymphoma and human leukemia cell lines by a calcium-binding protein complex, calprotectin, derived from inflammatory peritoneal exudate cells. | Q50756265 | ||
Array comparative genomic hybridization of keratoacanthomas and squamous cell carcinomas: different patterns of genetic aberrations suggest two distinct entities. | Q51789946 | ||
The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma. | Q53421043 | ||
Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells. | Q53538275 | ||
Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma. | Q53617377 | ||
Keratoacanthoma with perineural invasion: a report of 40 cases | Q74318363 | ||
Keratoacanthoma vs. squamous cell carcinoma in contrast with keratoacanthoma is squamous cell carcinoma | Q76382916 | ||
Keratoacanthoma: is it really a variant of squamous cell carcinoma? | Q84471819 | ||
P433 | issue | 6 | |
P304 | page(s) | 799-806 | |
P577 | publication date | 2015-02-13 | |
P1433 | published in | Modern Pathology | Q15724578 |
P1476 | title | Keratoacanthoma and squamous cell carcinoma are distinct from a molecular perspective. | |
P478 | volume | 28 |
Q39159797 | Advances in histopathological diagnosis of keratoacanthoma |
Q47247906 | Carcinogenicity assessment of the Hedgehog pathway inhibitor, vismodegib in Tg.rasH2 mice and Sprague-Dawley rats |
Q55054189 | Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders? |
Q52840835 | Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors. |
Q52780270 | Keratoacanthoma en plaque/nodule: A brief report of the clinicopathological features of five cases. |
Q47761170 | Keratoacanthoma management: results of a survey of U.K. dermatologists and surgeons. |
Q38609786 | Keratoacanthoma: a distinct entity? |
Q55495010 | MALAT1: A long non-coding RNA highly associated with human cancers. |
Q93048531 | Patterns of LC3A Autophagy Protein Expression in Keratoacanthomas |
Q38870754 | Squamous cell carcinoma and keratoacanthomas are biologically distinct and can be diagnosed by light microscopy: a review |
Q91776664 | Study of Gene Expression Profiles of Breast Cancers in Indian Women |
Q64915753 | TPM4 promotes cell migration by modulating F-actin formation in lung cancer. |
Q52847150 | The distinction of keratoacanthoma from various types of squamous cell carcinoma with crateriform architecture. |